Please sign in to follow a disease.

Extensively drug-resistant tuberculosis

MONDO:0100482

A type of drug-resistant tuberculosis that is resistant to any fluoroquinolone, and at least one of three second-line injectable drugs (capreomycin, kanamycin, and amikacin), in addition to resistance to rifampicin and isoniazid.

Also known as: XDR-TB

11 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Infectious disease (282) Tuberculosis (201) Bacterial infectious disease (93) Mycobacterial infectious disease (23) Human disease (14) Drug-resistant tuberculosis (8) Disease by etiologic mechanism (0) Disease of primarily extrinsic mechanism (0) Primary bacterial infectious disease (0)

Trials to join now! 3 Not yet recruiting 4 Not yet finished but already full! 1 Completed 3

Can a new TB vaccine protect children with HIV?

⭐️ VACCINE ⭐️ Terminated

This trial is testing two tuberculosis (TB) vaccines—VPM1002 and a repeat BCG vaccination—in pre-adolescents aged 8-14 who were vaccinated at birth. The goal is to see if these vaccines are safe and trigger a strong immune response in children both with and without HIV, and in th…

Phase: PHASE1, PHASE2 • Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group • Aim: ⭐️ VACCINE ⭐️

Last updated Aug 18, 2026 06:00 UTC

Extensively drug-resistant tuberculosis

Broader categories

Can a new TB vaccine protect children with HIV?